US Food and Drug Administration (FDA) approved two gene therapy treatments for sickle-cell disease last year, including the first CRISPR-based genome-editing therapy the agency has ever authorized. Both stem-cell transplants and gene therapy require chemotherapy before the treatment. Three rounds of chemotherapy and other treatments drove her cancer into remission, but she still struggles with…